This new article publication from Acta Pharmaceutica Sinica B, discusses how single-cell RNA sequencing reveals that Shen-Bai ...

Although deaths from cancer have gone down over the last couple decades, the disease remains one of the leading causes of death in the United States, just as it has for the last 75 years, according to ...

The Chan Zuckerberg Initiative (CZI) reports its latest AI model aimed at helping researchers better understand how cells ...

Elliot Godfrey, from Waddesdon in Buckinghamshire, suddenly began experiencing migraines in March following a family holiday ...

Germany has become one of the world’s leading destinations for advanced cancer care, offering cutting-edge therapies, ...

The firm is launching a Phase II trial of its dendritic cell vaccine following promising preliminary efficacy and favorable safety results in Phase I.

In eight tumors where patients failed immune checkpoint inhibitor (ICI) treatment, Plinabulin + radiation + PD-1 inhibitors demonstrated ...

Men around the world dealing with sexual impotence have been treated for years with the drug sildenafil, sold under brand ...

Our group has developed four groups of strategies to enhance uniform targeting of the antigenically heterogenous cancer cells and to eliminate the “cold” tumor phenotypes: 1) Cell-based ...

dendritic cells and macrophages which are directly engineered to recognize and attack cancer cells within the TME. By deploying these engineered immune cells, researchers aim to enhance the immune ...

Blastic plasmacytoid dendritic cell neoplasm is a type of blood cancer. It originates in plasmacytoid dendritic cells, a part of the immune system. Learn more.

PRESS RELEASE EnnoDC unveils the next generation of dendritic cell-targeting immunotherapies supported by new leadership and an evolved strategy Versatile new technology featuring an antibody fused ...